Holen Sie sich die Stockscreener-App
38.41
2.98%
-1.18
Vorhandelsmarkt:
39.75
1.34
+3.49%
Schlusskurs vom Vortag:
$39.59
Offen:
$40.39
24-Stunden-Volumen:
2.34M
Relative Volume:
2.30
Marktkapitalisierung:
$2.13B
Einnahmen:
$249.12M
Nettoeinkommen (Verlust:
$-90.19M
KGV:
-22.59
EPS:
-1.7
Netto-Cashflow:
$-88.21M
1W Leistung:
-23.12%
1M Leistung:
-33.67%
6M Leistung:
-44.78%
1J Leistung:
-37.94%
1-Tages-Spanne:
$38.10
$40.98
1-Wochen-Bereich:
$37.12
$51.18
52-Wochen-Spanne:
$37.12
$103.81
Procept Biorobotics Corp Stock (PRCT) Company Profile
Firmenname
Procept Biorobotics Corp
Sektor
Branche
Telefon
(650) 232-9832
Adresse
150 BAYTECH DRIVE, SAN JOSE
Vergleichen Sie PRCT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
38.41 | 2.53B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-09 | Eingeleitet | Stephens | Overweight |
| 2025-07-07 | Eingeleitet | Oppenheimer | Perform |
| 2024-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Eingeleitet | Jefferies | Hold |
| 2023-08-11 | Eingeleitet | Piper Sandler | Overweight |
| 2023-05-31 | Eingeleitet | William Blair | Outperform |
| 2022-10-31 | Eingeleitet | BTIG Research | Neutral |
| 2022-10-25 | Eingeleitet | Truist | Buy |
| 2022-09-02 | Eingeleitet | Wells Fargo | Overweight |
| 2022-07-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-10-11 | Eingeleitet | Cowen | Outperform |
| 2021-10-11 | Eingeleitet | Goldman | Neutral |
| 2021-10-11 | Eingeleitet | Guggenheim | Buy |
| 2021-10-11 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Procept Biorobotics Corp Aktie (PRCT) Neueste Nachrichten
Procept BioRobotics Grows Fast Despite Wall Street Skepticism - Finimize
PROCEPT BioRobotics Reports Strong Q2 2025 Growth - TipRanks
Procept Biorobotics Reports Strong Q2 Growth Amid Challenges - TipRanks
PROCEPT BioRobotics outlines $325.5M 2025 revenue target amid leadership transition and margin expansion - MSN
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q2 2025 Earnings Call Transcript - MSN
What You Can Learn From PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) P/S After Its 34% Share Price Crash - simplywall.st
Why PROCEPT BioRobotics Corporation stock attracts strong analyst attentionFast Return Equity Trade Forecast Points to Small Caps - beatles.ru
Edwards’ Longtime TAVR Leader is Named PROCEPT BioRobotics CEO - Medical Product Outsourcing
A Quick Look at Today's Ratings for PROCEPT BioRobotics(PRCT.US), With a Forecast Between $55 to $83 - 富途牛牛
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Just Reported, And Analysts Assigned A US$65.75 Price Target - simplywall.st
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), Amgen (AMGN) and Qiagen (QGEN) - The Globe and Mail
PROCEPT BioRobotics 2025 Q2 Earnings Improved Losses Amid Revenue Surge - AInvest
PROCEPT BioRobotics Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Buy Rating for PROCEPT BioRobotics: Growth Potential and Stability Amid Sales Beat and Improved Guidance - TipRanks
A Quick Look at Today's Ratings for PROCEPT BioRobotics(PRCT.US), With a Forecast Between $85 to $85 - 富途牛牛
Procept Biorobotics Corp.’s Aquablation Therapy: A Promising Update for Prostate Cancer Treatment - TipRanks
Earnings call transcript: Procept BioRobotics Q2 2025 beats forecasts, stock dips - Investing.com
Truist Lowers Price Target on PROCEPT BioRobotics to $64 From $70, Keeps Buy Rating - MarketScreener
Why PROCEPT BioRobotics Shares Are Tumbling - TipRanks
Optimistic Outlook on PROCEPT BioRobotics Amidst Medtech Sector Challenges - TipRanks
Wells Fargo lowers Procept BioRobotics stock price target on delayed system replacements - Investing.com
PROCEPT BioRobotics (PRCT): Assessing the Path to Profitability Amid Leadership Transition and Global Expansion - AInvest
Procept (PRCT) Q2 Revenue Jumps 48% - The Globe and Mail
Procept (PRCT) Q2 Revenue Jumps 48% - The Motley Fool
PROCEPT BioRobotics (PRCT) Earnings Transcript - Mitrade
Procept Biorobotics earnings beat by $0.06, revenue topped estimates - Investing.com South Africa
PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Zimmer Biomet (ZBH) Q2 Revenue Jumps 7% - AOL.com
PROCEPT BioRobotics Q2 revenue up 48% YoY to $79.2mln. - AInvest
PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results - TradingView
Procept BioRobotics Q2 revenue up 48%, beats estimates - MarketScreener
PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance - GlobeNewswire
Procept Biorobotics stock hits 52-week low at 47.0 USD - Investing.com India
Procept Biorobotics stock hits 52-week low at 47.0 USD By Investing.com - Investing.com Canada
Edwards Veteran Wood Departs for CEO Gig - Orange County Business Journal
Should I hold or sell PROCEPT BioRobotics Corporation stock in 2025Unlock expert stock analysis and alerts - Jammu Links News
Is it the right time to buy PROCEPT BioRobotics Corporation stockBuild a diversified portfolio for sustainable growth - Jammu Links News
What drives PROCEPT BioRobotics Corporation stock priceGet professional advice for portfolio optimization - Jammu Links News
When is PROCEPT BioRobotics Corporation stock expected to show significant growthDynamic investment opportunities - Jammu Links News
How does PROCEPT BioRobotics Corporation compare to its industry peersRapid wealth multiplication - Jammu Links News
What are the latest earnings results for PROCEPT BioRobotics CorporationRemarkable growth - Jammu Links News
What is PROCEPT BioRobotics Corporation company’s growth strategyGet expert analysis on top stock picks - Jammu Links News
Is PROCEPT BioRobotics Corporation a growth stock or a value stockInvest smarter with daily stock recommendations - Jammu Links News
Published on: 2025-08-03 05:58:47 - Jammu Links News
What institutional investors are buying PROCEPT BioRobotics Corporation stockAccelerated wealth expansion - Jammu Links News
PROCEPT BioRobotics to Announce Q2 2025 Earnings on August 6, 2025 - AInvest
Quant Funds Rotate Into PROCEPT BioRobotics Corporation StockTechnical Entry Strategy for Beginners Explained - metal.it
Market reaction to PROCEPT BioRobotics Corporation’s recent newsSmart Allocation Stock Pick Insights Gaining Interest - metal.it
RSI Alert: PROCEPT BioRobotics (PRCT) Now Oversold - Nasdaq
What are analysts’ price targets for PROCEPT BioRobotics Corporation in the next 12 monthsBeginner Investor Planner With Proven Results - Jammu Links News
Will PROCEPT BioRobotics Corporation (PRCT) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Finanzdaten der Procept Biorobotics Corp-Aktie (PRCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):